Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)
Recruiting now
Conditions studied: Dysphonia, Connective Tissue Disease, Vasculitis
In brief
The goal of this multicenter retrospective observational study is to provide an inventory of the specific and non specific cord vocal lesions that can cause dysphonia in patients with systemic autoimmune diseases. The main question it aims to answer is: * What are the main cord vocal lesions responsible for dysphonia in patients with a systemic autoimmune disease? * Is there a diagnosis delay regarding those lesions? * How are those lesions managed? Participants suffering from dysphonia in a context of a systemic autoimmune disease will be identified, with a review of their medical record.
Key facts
- Study ID
- NCT06779799
- Run by
- University Hospital, Brest
- People needed
- 150
- Starts
- 2024-12-01
- Expected to finish
- 2025-05-31
- Last updated by the study team
- 2025-01-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients aged 18 years or older
- With a systemic autoimmune disease : rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, primary Sjogren disease, sarcoidosis, vasculitis, myositis, Still disease, Sharp syndrome.
- Suffering from dysphonia.
- With a cord vocal/laryngeal lesion highlighted.
You may not qualify if…
- Patients under the age of 18 years
- Dysphonia due to a cord vocal palsy related to a neurological condition or malignancy
- History of cervical radiation
- History of oro-tracheal intubation
- Laryngeal cancer
- Participation deny
- Impossibility of consent
- Patients with legal protection
Where it is running
- Chu Brest — Brest, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.